TL;DR

Optimization is impossible without trustworthy measurement — and measurement is where microdosing claims are weakest. Effect size asks not “is there a difference?” but “is it large enough to matter?”, and small or absent effects are the norm in controlled low-dose data. [1] Systematic review The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field Polito V, Liknaitzky P (2022) doi:10.1016/j.neubiorev.2022.104706 Self-tracking cannot establish cause: with no control and no blinding, it confuses confounding with causation. [2] Clinical trial Self-blinding citizen science to explore psychedelic microdosing Szigeti B, Kartner L, Blemings A, Rosas F, Feilding A, Nutt DJ, Carhart-Harris RL, Erritzoe D (2021) doi:10.7554/eLife.62878 You cannot optimize what you cannot measure cleanly.

Education-only methodology orientation. Not medical advice. This explains measurement concepts, not a tracking protocol to follow.

How the field studies optimization — not instructions to optimize a practice. No dose, stack, schedule, cycling plan, titration method, tolerance-management strategy, or personal optimization protocol appears anywhere in this cluster.

Significance is not size

A statistically significant result only says a difference is unlikely to be pure chance; it says nothing about whether the difference is big enough to care about. Effect size fills that gap, and it is the quantity that meta-analyses combine across studies. [1] Systematic review The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field Polito V, Liknaitzky P (2022) doi:10.1016/j.neubiorev.2022.104706 In microdosing, keeping the focus on effect size guards against the trap of treating any detectable blip as a meaningful benefit worth optimizing.

Why self-tracking cannot establish cause

What a measurement approach can and cannot establish
ApproachCan establishCannot establish
Blinded RCTWhether the drug caused the effect, and its sizeLittle from one study without replication
Observational cohortAssociationsCausation; self-selection confounds [3] Observational A systematic study of microdosing psychedelics Polito V, Stevenson RJ (2019) doi:10.1371/journal.pone.0211023
Personal self-trackingHow you felt over timeThat the dose caused the change

The moment you start tracking, several things change at once — attention, motivation, expectation, often diet or sleep. These are confounders: factors tied to both the practice and the outcome. Because self-tracking has no control condition, it cannot pull them apart, and improvement after starting almost any deliberate routine is the expected pattern, not evidence of a drug effect. [2] Clinical trial Self-blinding citizen science to explore psychedelic microdosing Szigeti B, Kartner L, Blemings A, Rosas F, Feilding A, Nutt DJ, Carhart-Harris RL, Erritzoe D (2021) doi:10.7554/eLife.62878

Self-experimentation’s built-in problem

Self-experimentation feels rigorous because it is systematic and personal, but it inherits every confound above and adds the strongest one — you know what you took. That single fact lets expectation drive the result. The self-blinding study exists precisely to neutralise it, and when it did, the apparent benefit shrank toward placebo.

Optimizing the wrong target

Even when something is being measured, optimization can quietly lock onto the wrong target. A routine can be optimized for noticing an effect, for confirming an expectation, for maintaining a satisfying ritual, or for feeling more in control — none of which is the same as showing the compound improved the intended outcome. Optimizing for mood, focus, creativity, anxiety, sleep, and productivity are also distinct research questions, not interchangeable goals, so a single regimen cannot be “optimal” for all of them at once. This is why defining the outcome in advance is not a formality: without it, deliberate adjustment produces a feeling of precision around a target no one ever specified.

Measurement is the precondition for optimization

This is the link back to the cluster’s thesis. Optimization means adjusting something to improve a measured outcome. If the outcome cannot be measured without confounding, then no adjustment can be evaluated, and “optimization” becomes expectation-guided guessing. [4] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research Kuypers KPC, Ng L, Erritzoe D, Knudsen GM, Nichols CD, Nichols DE, Pani L, Soula A, Nutt D (2019) doi:10.1177/0269881119857204 Clean measurement — controls, blinding, a real effect-size estimate — is not a refinement of optimization; it is its prerequisite.

Key concepts
Size over significance
Ask how large, not just whether detectable. [1] Systematic review The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field Polito V, Liknaitzky P (2022) doi:10.1016/j.neubiorev.2022.104706
Confounding ≠ causation
Self-tracking changes many things at once.
You know what you took
Unblinded self-experimentation lets expectation drive results. [2] Clinical trial Self-blinding citizen science to explore psychedelic microdosing Szigeti B, Kartner L, Blemings A, Rosas F, Feilding A, Nutt DJ, Carhart-Harris RL, Erritzoe D (2021) doi:10.7554/eLife.62878
Measure first
Optimization is impossible without clean measurement. [4] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research Kuypers KPC, Ng L, Erritzoe D, Knudsen GM, Nichols CD, Nichols DE, Pani L, Soula A, Nutt D (2019) doi:10.1177/0269881119857204

Frequently asked questions

What is effect size and why does it matter?

Effect size is a measure of how large an effect is, separate from whether it is statistically detectable. It matters because a result can be statistically significant yet too small to mean anything in daily life, and because pooling studies in meta-analysis requires a common measure of magnitude. In microdosing, asking about effect size keeps attention on whether any difference is meaningful, not just present.

Why can't my own tracking prove microdosing works for me?

Self-tracking has no comparison condition and no blinding, so it cannot separate a drug effect from expectation, natural variation, or the act of paying closer attention. You will often see improvement after starting almost any intentional practice, which is confounding rather than causation. Tracking can describe how you feel; it cannot establish that the microdose caused the change.

What is a confounder, concretely?

A confounder is a third factor linked to both the supposed cause and the outcome that distorts their apparent relationship. In microdosing, motivation, lifestyle changes, expectation, and self-selection are classic confounders: people who start microdosing often change other things at the same time, so any improvement cannot be attributed to the dose without controlling for them.

How does this connect to optimization?

Optimization is meaningless without a trustworthy measure of outcome. If you cannot measure an effect cleanly, you cannot tell whether any change you made improved it, so optimization collapses into guessing guided by expectation. Sound measurement, with controls and a real effect-size estimate, is the precondition for ever speaking sensibly about optimizing anything.